Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-11.7%
5Y CAGR-27.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-11.7%/yr
vs -15.1%/yr prior
5Y CAGR
-27.5%/yr
Recent acceleration
Acceleration
+3.4pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.16 | -68.9% |
| 2023 | 3.72 | -3.9% |
| 2022 | 3.87 | +130.1% |
| 2021 | 1.68 | +8.9% |
| 2020 | 1.54 | -73.2% |
| 2019 | 5.76 | +23.6% |
| 2018 | 4.66 | +43.7% |
| 2017 | 3.24 | +37.6% |
| 2016 | 2.35 | -58.0% |
| 2015 | 5.61 | - |